Foundation Medicine Stock Filter Stocks by Fundamentals
Foundation Medicine fundamentals help investors to digest information that contributes to Foundation Medicine's financial success or failures. It also enables traders to predict the movement of Foundation Stock. The fundamental analysis module provides a way to measure Foundation Medicine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Foundation Medicine stock.
Foundation |
Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
All Next | Launch Module |
Foundation Fundamentals
Return On Equity | -2.0E-4 | |||
Return On Asset | -1.0E-4 | |||
Profit Margin | (0.0001) % | |||
Operating Margin | (83.98) % | |||
Current Valuation | 5.09 B | |||
Shares Outstanding | 37.14 M | |||
Shares Owned By Insiders | 58.74 % | |||
Shares Owned By Institutions | 36.24 % | |||
Number Of Shares Shorted | 2.35 M | |||
Price To Earning | (9.70) X | |||
Price To Book | 267.58 X | |||
Price To Sales | 28.36 X | |||
Revenue | 179.42 M | |||
Gross Profit | (23.88 M) | |||
EBITDA | (189.96 M) | |||
Net Income | (152.43 M) | |||
Cash And Equivalents | 60.29 M | |||
Cash Per Share | (3.70) X | |||
Total Debt | 90 M | |||
Debt To Equity | 476.20 % | |||
Current Ratio | 2.27 X | |||
Book Value Per Share | 7.26 X | |||
Cash Flow From Operations | (118.24 M) | |||
Short Ratio | 6.56 X | |||
Earnings Per Share | (4.21) X | |||
Number Of Employees | 662 | |||
Beta | 1.54 | |||
Market Capitalization | 5.09 B | |||
Total Asset | 297.99 M | |||
Retained Earnings | (287.39 M) | |||
Working Capital | 199.75 M | |||
Current Asset | 229.64 M | |||
Current Liabilities | 29.9 M | |||
Z Score | 33.6 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Foundation Stock
If you are still planning to invest in Foundation Medicine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Foundation Medicine's history and understand the potential risks before investing.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |